Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial – The Lancet Oncology (free for a limited period)   Commentary on Twitter Our phase III randomized study, published in Lancet Oncology today, showed high-dose steroid didn’t improve SOB and should not be used routinely in pts with lung […]

The post RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events. appeared first on Links Medicus.